{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:19:59Z","timestamp":1791227999861,"version":"4.1.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T00:00:00Z","timestamp":1398816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11011-014-9551-2","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T02:41:08Z","timestamp":1398739268000},"page":"593-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Interleukin 6 and cognitive dysfunction"],"prefix":"10.1007","volume":"29","author":[{"given":"Isabel","family":"Trapero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Cauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"key":"9551_CR1","doi-asserted-by":"crossref","unstructured":"ACR (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599\u2013608","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"key":"9551_CR2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/exnr.1995.1082","volume":"136","author":"Y Akaneya","year":"1995","unstructured":"Akaneya Y, Takahashi M, Hatanaka H (1995) Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp Neurol 136:44\u201352","journal-title":"Exp Neurol"},{"key":"9551_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S et al (2000) Inflammation and Alzheimer's disease. Neurobiology of Aging 21:383\u2013421","journal-title":"Neurobiology of Aging"},{"issue":"Pt 11","key":"9551_CR4","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tas\u00e7i B (1999) Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group Brain 122(Pt 11):2171\u20132182","journal-title":"The Neuro-Beh\u00e7et Study Group. Brain"},{"key":"9551_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","volume":"44","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir G, T\u00fcz\u00fcn E, I\u00e7\u00f6z S et al (2008) Interleukin-6 in neuro-Beh\u00e7et's disease: association with disease subsets and long-term outcome. Cytokine 44:373\u2013376","journal-title":"Cytokine"},{"key":"9551_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4037\/ajcc2014578","volume":"23","author":"SA Alexander","year":"2014","unstructured":"Alexander SA, Ren D, Gunn SR et al (2014) Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients. Am J Crit Care 23:49\u201357","journal-title":"Am J Crit Care"},{"key":"9551_CR7","first-page":"292","volume":"21","author":"A Amirzargar","year":"2010","unstructured":"Amirzargar A, Shahram F, Nikoopour E et al (2010) Proinflammatory cytokine gene polymorphisms in Beh\u00e7et's disease. Eur Cytokine Netw 21:292\u2013296","journal-title":"Eur Cytokine Netw"},{"key":"9551_CR8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/02699050110104435","volume":"16","author":"A Amos","year":"2002","unstructured":"Amos A (2002) Remediating deficits of switching attention in patients with acquired brain injury. Brain Inj 16:407\u2013413","journal-title":"Brain Inj"},{"key":"9551_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1440-1789.2006.00651.x","volume":"26","author":"E Andriambeloson","year":"2006","unstructured":"Andriambeloson E, Baillet C, Vitte P-A et al (2006) Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Neuropathology 26:32\u201342","journal-title":"Neuropathology"},{"key":"9551_CR10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0304-3940(98)00136-0","volume":"244","author":"P Angelis","year":"1998","unstructured":"Angelis P, Scharf S, Mander A et al (1998) Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease. Neurosci Lett 244:106\u2013108","journal-title":"Neurosci Lett"},{"key":"9551_CR11","first-page":"77","volume":"48","author":"T Arai","year":"1994","unstructured":"Arai T, Mizukami K, Sasaki M et al (1994) Clinicopathological study on a case of neuro-Beh\u00e7et's disease: in special reference to MRI, SPECT and neuropathological findings. Jpn J Psychiatry Neurol 48:77\u201384","journal-title":"Jpn J Psychiatry Neurol"},{"key":"9551_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1242\/dev.118.1.283","volume":"118","author":"BA Barres","year":"1993","unstructured":"Barres BA, Schmid R, Sendnter M, Raff MC (1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283\u2013295","journal-title":"Development"},{"key":"9551_CR13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.exger.2012.07.002","volume":"47","author":"A Baskys","year":"2012","unstructured":"Baskys A, Cheng J-X (2012) Pharmacological prevention and treatment of vascular dementia: approaches and perspectives. Experimental Gerontology 47:887\u2013891","journal-title":"Experimental Gerontology"},{"key":"9551_CR14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0923-2494(92)80051-L","volume":"143","author":"J Bauer","year":"1992","unstructured":"Bauer J, Ganter U, Strauss S et al (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res Immunol 143:650\u2013657","journal-title":"Res Immunol"},{"key":"9551_CR15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0923-2494(92)80052-M","volume":"143","author":"F Berkenbosch","year":"1992","unstructured":"Berkenbosch F, Biewenga J, Brouns M et al (1992) Cytokines and inflammatory proteins in Alzheimer's disease. Res Immunol 143:657\u2013663","journal-title":"Res Immunol"},{"key":"9551_CR16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.imlet.2008.02.002","volume":"117","author":"P Bermejo","year":"2008","unstructured":"Bermejo P, Mart\u00edn-Arag\u00f3n S, Bened\u00ed J et al (2008) Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunology Letters 117:198\u2013202","journal-title":"Immunology Letters"},{"key":"9551_CR17","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/sj.npp.1301612","volume":"33","author":"K Biber","year":"2008","unstructured":"Biber K, Pinto-Duarte A, Wittendorp MC et al (2008) Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology 33:2237\u20132250","journal-title":"Neuropsychopharmacology"},{"key":"9551_CR18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, M\u00fcller T, Kuhn W et al (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u201cs and de novo Parkinson\u201ds disease patients. Neurosci Lett 202:17\u201320","journal-title":"Neurosci Lett"},{"key":"9551_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clineuro.2009.02.001","volume":"111","author":"A Borhani Haghighi","year":"2009","unstructured":"Borhani Haghighi A, Ittehadi H, Nikseresht AR et al (2009) CSF levels of cytokines in neuro-Beh\u00e7et's disease. Clin Neurol Neurosurg 111:507\u2013510","journal-title":"Clin Neurol Neurosurg"},{"key":"9551_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1053-0770(96)80185-6","volume":"10","author":"LM Borowicz","year":"1996","unstructured":"Borowicz LM, Goldsborough MA, Selnes OA, McKhann GM (1996) Neuropsychologic change after cardiac surgery: a critical review. J Cardiothorac Vasc Anesth 10:105\u2013112","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"9551_CR21","first-page":"2101","volume":"300","author":"MJ Boulanger","year":"2003","unstructured":"Boulanger MJ, Chow D-C, Brevnova EE, Garcia KC (2003) Hexameric Structure and Assembly of the Interleukin-6\/IL-6 {alpha}-Receptor\/gp130 Complex. Science Signaling 300:2101\u20132104","journal-title":"Science Signaling"},{"key":"9551_CR22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/hep.21734","volume":"46","author":"O Cauli","year":"2007","unstructured":"Cauli O, Rodrigo R, Piedrafita B et al (2007) Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 46:514\u2013519","journal-title":"Hepatology"},{"key":"9551_CR23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1749-6632.2009.04670.x","volume":"1173","author":"S Cavaco","year":"2009","unstructured":"Cavaco S, da Silva AM, Pinto P et al (2009) Cognitive functioning in Beh\u00e7et's disease. Ann N Y Acad Sci 1173:217\u2013226","journal-title":"Ann N Y Acad Sci"},{"key":"9551_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S1355617797001793","volume":"3","author":"SP Cercy","year":"1997","unstructured":"Cercy SP, Bylsma FW (1997) Lewy bodies and progressive dementia: a critical review and meta-analysis. J Int Neuropsychol Soc 3:179\u2013194","journal-title":"J Int Neuropsychol Soc"},{"key":"9551_CR25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/gerona\/59.3.M242","volume":"59","author":"M Cesari","year":"2004","unstructured":"Cesari M, Penninx BWJH, Pahor M et al (2004) Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 59:242\u2013248","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"9551_CR26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/ard.2004.024208","volume":"64","author":"HK Chang","year":"2005","unstructured":"Chang HK, Jang WC, Park SB et al (2005) Association between interleukin 6 gene polymorphisms and Behcet's disease in Korean people. Ann Rheum Dis 64:339\u2013340","journal-title":"Ann Rheum Dis"},{"key":"9551_CR27","first-page":"2150","volume":"291","author":"D-C Chow","year":"2001","unstructured":"Chow D-C, He X-L, Snow AL et al (2001) Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex. Science Signaling 291:2150\u20132155","journal-title":"Science Signaling"},{"key":"9551_CR28","first-page":"1849","volume":"34","author":"CP Chung","year":"2007","unstructured":"Chung CP, Oeser A, Solus J et al (2007) Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus. J Rheumatol 34:1849\u20131854","journal-title":"J Rheumatol"},{"key":"9551_CR29","first-page":"55","volume":"49","author":"IM Cojocaru","year":"2011","unstructured":"Cojocaru IM, Cojocaru M, Miu G, Sapira V (2011) Study of interleukin-6 production in Alzheimer's disease. Rom J Intern Med 49:55\u201358","journal-title":"Rom J Intern Med"},{"key":"9551_CR30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1460-9568.2000.00011.x","volume":"12","author":"G D'Arcangelo","year":"2000","unstructured":"D'Arcangelo G, Tancredi V, Onofri F et al (2000) Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex. Eur J Neurosci 12:1241\u20131252","journal-title":"Eur J Neurosci"},{"key":"9551_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s100670050045","volume":"18","author":"EM Davas","year":"1999","unstructured":"Davas EM, Tsirogianni A, Kappou I et al (1999) Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17\u201322","journal-title":"Clin Rheumatol"},{"key":"9551_CR32","first-page":"R739","volume":"265","author":"MG Simoni De","year":"1993","unstructured":"De Simoni MG, De Luigi A, Gemma L et al (1993) Modulation of systemic interleukin-6 induction by central interleukin-1. Am J Physiol 265:R739\u201342","journal-title":"Am J Physiol"},{"key":"9551_CR33","first-page":"485","volume":"30","author":"R Dellalibera-Joviliano","year":"2003","unstructured":"Dellalibera-Joviliano R, Reis Dos ML, Cunha F, De Q, Donadi EA (2003) Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus. J Rheumatol 30:485\u2013492","journal-title":"J Rheumatol"},{"key":"9551_CR34","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1128\/MCB.14.7.4443","volume":"14","author":"U Dendorfer","year":"1994","unstructured":"Dendorfer U, Oettgen P, Libermann TA (1994) Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 14:4443\u20134454","journal-title":"Mol Cell Biol"},{"key":"9551_CR35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0006-8993(96)00865-7","volume":"740","author":"E Santo Di","year":"1996","unstructured":"Di Santo E, Alonzi T, Fattori E et al (1996) Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production. Brain Res 740:239\u2013244","journal-title":"Brain Res"},{"key":"9551_CR36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0361-9230(92)90148-Q","volume":"29","author":"AJ Dunn","year":"1992","unstructured":"Dunn AJ (1992) The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Res Bull 29:807\u2013812","journal-title":"Brain Res Bull"},{"key":"9551_CR37","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00415-011-6319-z","volume":"259","author":"LA Dutra","year":"2012","unstructured":"Dutra LA, Gon\u00e7alves CR, Braga-Neto P et al (2012) Atypical manifestations in Brazilian patients with neuro-Beh\u00e7et's disease. J Neurol 259:1159\u20131165","journal-title":"J Neurol"},{"key":"9551_CR38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000343276","volume":"40","author":"A Economos","year":"2013","unstructured":"Economos A, Wright CB, Moon YP et al (2013) Interleukin 6 Plasma Concentration Associates with Cognitive Decline: The Northern Manhattan Study. Neuroepidemiology 40:253\u2013259","journal-title":"Neuroepidemiology"},{"key":"9551_CR39","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/01.HYP.0000051642.65283.36","volume":"41","author":"K Egashira","year":"2003","unstructured":"Egashira K (2003) Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension 41:834\u2013841","journal-title":"Hypertension"},{"key":"9551_CR40","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","volume":"61","author":"MJ Engelhart","year":"2004","unstructured":"Engelhart MJ, Geerlings MI, Meijer J et al (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol 61:668\u2013672","journal-title":"Arch Neurol"},{"key":"9551_CR41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","volume":"51","author":"WB Ershler","year":"2000","unstructured":"Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245\u2013270","journal-title":"Annu Rev Med"},{"key":"9551_CR42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1532-5415.1997.tb00986.x","volume":"45","author":"LP Fried","year":"1997","unstructured":"Fried LP, Guralnik JM (1997) Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc 45:92\u2013100","journal-title":"J Am Geriatr Soc"},{"key":"9551_CR43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0304-3940(94)90807-9","volume":"182","author":"RA Gadient","year":"1994","unstructured":"Gadient RA, Otten U (1994a) Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett 182:243\u2013246","journal-title":"Neurosci Lett"},{"key":"9551_CR44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(93)90065-S","volume":"153","author":"RA Gadient","year":"1993","unstructured":"Gadient RA, Otten U (1993) Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci Lett 153:13\u201316","journal-title":"Neurosci Lett"},{"key":"9551_CR45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(94)91211-4","volume":"637","author":"RA Gadient","year":"1994","unstructured":"Gadient RA, Otten U (1994b) Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 637:10\u201314","journal-title":"Brain Res"},{"key":"9551_CR46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0301-0082(97)00021-X","volume":"52","author":"RA Gadient","year":"1997","unstructured":"Gadient RA, Otten UH (1997) Interleukin-6 (IL-6)\u2013a molecule with both beneficial and destructive potentials. Prog Neurobiol 52:379\u2013390","journal-title":"Prog Neurobiol"},{"key":"9551_CR47","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.biopsych.2011.11.018","volume":"71","author":"F Garcia-Oscos","year":"2012","unstructured":"Garcia-Oscos F, Salgado H, Hall S et al (2012) The stress-induced cytokine interleukin-6 decreases the inhibition\/excitation ratio in the rat temporal cortex via trans-signaling. Biological Psychiatry 71:574\u2013582","journal-title":"Biological Psychiatry"},{"key":"9551_CR48","first-page":"203","volume":"60","author":"J Gauldie","year":"1987","unstructured":"Gauldie J, Sauder DN, McAdam KP, Dinarello CA (1987) Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunology 60:203\u2013207","journal-title":"Immunology"},{"key":"9551_CR49","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.psyneuen.2012.11.004","volume":"38","author":"M Girotti","year":"2012","unstructured":"Girotti M, Donegan JJ, Morilak DA (2012) Influence of hypothalamic IL-6\/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology 38:1158\u20131169","journal-title":"Psychoneuroendocrinology"},{"key":"9551_CR50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3181\/00379727-205-43695","volume":"205","author":"MN Goodman","year":"1994","unstructured":"Goodman MN (1994) Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 205:182\u2013185","journal-title":"Proc Soc Exp Biol Med"},{"key":"9551_CR51","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archneur.60.9.1218","volume":"60","author":"E G\u00f3mez-Tortosa","year":"2003","unstructured":"G\u00f3mez-Tortosa E, Gonzalo I, Fanjul S et al (2003) Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease. Arch Neurol 60:1218\u20131222","journal-title":"Arch Neurol"},{"key":"9551_CR52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02740665","volume":"15","author":"DL Gruol","year":"1997","unstructured":"Gruol DL, Nelson TE (1997) Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15:307\u2013339","journal-title":"Mol Neurobiol"},{"key":"9551_CR53","first-page":"152","volume":"3","author":"C Guzm\u00e1n","year":"2010","unstructured":"Guzm\u00e1n C, Hallal-Calleros C (2010) Interleukin-6: a cytokine with a pleiotropic role in the neuroimmunoendocrine network. The Open Neuroendocrinology Journal 3:152\u2013160","journal-title":"The Open Neuroendocrinology Journal"},{"key":"9551_CR54","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/00207454.2012.704454","volume":"122","author":"T G\u00fcnd\u00fcz","year":"2012","unstructured":"G\u00fcnd\u00fcz T, Emir \u00d6, K\u00fcrt\u00fcnc\u00fc M et al (2012) Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study. Int J Neurosci 122:650\u2013656","journal-title":"Int J Neurosci"},{"key":"9551_CR55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0306-4522(91)90132-8","volume":"40","author":"T Hama","year":"1991","unstructured":"Hama T, Kushima Y, Miyamoto M et al (1991) Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 40:445\u2013452","journal-title":"Neuroscience"},{"key":"9551_CR56","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-5223(19)35280-8","volume":"96","author":"TA Hammeke","year":"1988","unstructured":"Hammeke TA, Hastings JE (1988) Neuropsychologic alterations after cardiac operation. J Thorac Cardiovasc Surg 96:326\u2013331","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9551_CR57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00406-004-0558-2","volume":"255","author":"H Hampel","year":"2005","unstructured":"Hampel H, Haslinger A, Scheloske M et al (2005) Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain. Eur Arch Psychiatry Clin Neurosci 255:269\u2013278","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"9551_CR58","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/art.1780400825","volume":"40","author":"JG Hanly","year":"1997","unstructured":"Hanly JG, Cassell K, Fisk JD (1997) Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 40:1542\u20131543","journal-title":"Arthritis Rheum"},{"key":"9551_CR59","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3899\/jrheum.111504","volume":"39","author":"JG Hanly","year":"2012","unstructured":"Hanly JG, Su L, Omisade A et al (2012) Screening for cognitive impairment in systemic lupus erythematosus. J Rheumatol 39:1371\u20131377","journal-title":"J Rheumatol"},{"key":"9551_CR60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.22305","volume":"56","author":"JG Hanly","year":"2007","unstructured":"Hanly JG, Urowitz MB, Sanchez-Guerrero J et al (2007) Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 56:265\u2013273","journal-title":"Arthritis Rheum"},{"key":"9551_CR61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/ard.53.5.298","volume":"53","author":"EM Hay","year":"1994","unstructured":"Hay EM, Huddy A, Black D et al (1994) A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann Rheum Dis 53:298\u2013303","journal-title":"Ann Rheum Dis"},{"issue":"Pt 2","key":"9551_CR62","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","volume":"334","author":"PC Heinrich","year":"1998","unstructured":"Heinrich PC, Behrmann I, M\u00fcller-Newen G et al (1998) Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway. Biochem J 334(Pt 2):297\u2013314","journal-title":"Biochem J"},{"key":"9551_CR63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-5223(19)39177-9","volume":"86","author":"L Henriksen","year":"1983","unstructured":"Henriksen L, Hjelms E, Lindeburgh T (1983) Brain hyperperfusion during cardiac operations. Cerebral blood flow measured in man by intra-arterial injection of xenon 133: evidence suggestive of intraoperative microembolism. J Thorac Cardiovasc Surg 86:202\u2013208","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9551_CR64","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2169\/naika.85.1816","volume":"85","author":"S Hirohata","year":"1996","unstructured":"Hirohata S (1996) Coping with pathological changes in nerves and blood vessels in collagen disease\u2013CNS lupus. Nippon Naika Gakkai Zasshi 85:1816\u20131821","journal-title":"Nippon Naika Gakkai Zasshi"},{"key":"9551_CR65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","volume":"82","author":"S Hirohata","year":"1997","unstructured":"Hirohata S, Isshi K, Oguchi H et al (1997) Cerebrospinal fluid interleukin-6 in progressive Neuro-Beh\u00e7et's syndrome. Clin Immunol Immunopathol 82:12\u201317","journal-title":"Clin Immunol Immunopathol"},{"key":"9551_CR66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/ar757","volume":"5","author":"S Hirohata","year":"2003","unstructured":"Hirohata S, Kikuchi H (2003) Beh\u00e7et's disease. Arthritis Res Ther 5:139\u2013146","journal-title":"Arthritis Res Ther"},{"key":"9551_CR67","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.2169\/internalmedicine.51.8583","volume":"51","author":"S Hirohata","year":"2012","unstructured":"Hirohata S, Kikuchi H (2012) Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Beh\u00e7et's disease. Intern Med 51:3359\u20133365","journal-title":"Intern Med"},{"key":"9551_CR68","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/art.1780330506","volume":"33","author":"S Hirohata","year":"1990","unstructured":"Hirohata S, Miyamoto T (1990) Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 33:644\u2013649","journal-title":"Arthritis Rheum"},{"key":"9551_CR69","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/BF00571510","volume":"89","author":"M Huell","year":"1995","unstructured":"Huell M, Strauss S, Volk B et al (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol 89:544\u2013551","journal-title":"Acta Neuropathol"},{"key":"9551_CR70","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1749-6632.1996.tb34420.x","volume":"777","author":"M Hull","year":"1996","unstructured":"Hull M, Berger M, Volk B, Bauer J (1996a) Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques. Ann N Y Acad Sci 777:205\u2013212","journal-title":"Ann N Y Acad Sci"},{"key":"9551_CR71","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02189112","volume":"246","author":"M Hull","year":"1996","unstructured":"Hull M, Strauss S, Berger M et al (1996b) Inflammatory mechanisms in Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 246:124\u2013128","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"9551_CR72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00401-004-0919-y","volume":"109","author":"K Imamura","year":"2004","unstructured":"Imamura K, Hishikawa N, Ono K et al (2004) Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathol 109:141\u2013150","journal-title":"Acta Neuropathol"},{"key":"9551_CR73","first-page":"135","volume":"24","author":"G Inaba","year":"1984","unstructured":"Inaba G (1984) Revised criteria for the diagnosis of Beh\u00e7et's disease. Ryumachi 24:135\u2013141","journal-title":"Ryumachi"},{"key":"9551_CR74","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.dld.2012.07.002","volume":"44","author":"L Jain","year":"2012","unstructured":"Jain L, Sharma BC, Sharma P et al (2012) Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Dig Liver Dis 44:1027\u20131031","journal-title":"Dig Liver Dis"},{"key":"9551_CR75","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00415-009-5312-2","volume":"257","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009) Intrathecal levels of IL-6 in Alzheimer\u2019s disease. J Neurol 257:142\u2013142","journal-title":"J Neurol"},{"key":"9551_CR76","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/gerona\/glr261","volume":"67","author":"NS Jenny","year":"2012","unstructured":"Jenny NS, French B, Arnold AM et al (2012) Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J Gerontol A Biol Sci Med Sci 67:970\u2013976","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"9551_CR77","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.4049\/jimmunol.1302229","volume":"191","author":"R Ji","year":"2013","unstructured":"Ji R, Tian S, Lu HJ et al (2013) TAM receptors affect adult brain neurogenesis by negative regulation of microglial cell activation. J Immunol 191:6165\u20136177","journal-title":"J Immunol"},{"key":"9551_CR78","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2005.03.051","volume":"383","author":"JP Jia","year":"2005","unstructured":"Jia JP, Meng R, Sun YX et al (2005) Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia. Neurosci Lett 383:12\u201316","journal-title":"Neurosci Lett"},{"key":"9551_CR79","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1073858402008003012","volume":"8","author":"E J\u00fcttler","year":"2002","unstructured":"J\u00fcttler E, Tarabin V, Schwaninger M (2002) Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity. Neuroscientist 8:268\u2013275","journal-title":"Neuroscientist"},{"key":"9551_CR80","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0404.1997.tb00275.x","volume":"96","author":"J Kalman","year":"2009","unstructured":"Kalman J, Juhasz A, Laird G et al (2009) Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand 96:236\u2013240","journal-title":"Acta Neurol Scand"},{"key":"9551_CR81","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0404.1997.tb00275.x","volume":"96","author":"J Kalman","year":"1997","unstructured":"Kalman J, Juhasz A, Laird G et al (1997) Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand 96:236\u2013240","journal-title":"Acta Neurol Scand"},{"key":"9551_CR82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuint.2005.10.007","volume":"48","author":"J K\u00e1lm\u00e1n","year":"2006","unstructured":"K\u00e1lm\u00e1n J, Juh\u00e1sz A, Bog\u00e1ts G et al (2006) Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochemistry International 48:177\u2013180","journal-title":"Neurochemistry International"},{"key":"9551_CR83","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0304-3940(92)90209-P","volume":"145","author":"SS Kent","year":"1992","unstructured":"Kent SS, Kelley KWK, Dantzer RR (1992) Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist. Neurosci Lett 145:83\u201386","journal-title":"Neurosci Lett"},{"key":"9551_CR84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W","volume":"19","author":"MA Klein","year":"1997","unstructured":"Klein MA, M\u00f6ller JC, Jones LL et al (1997) Impaired neuroglial activation in interleukin-6 deficient mice. Glia 19:227\u2013233","journal-title":"Glia"},{"key":"9551_CR85","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","volume":"368","author":"M Kopf","year":"1994","unstructured":"Kopf M, Baumann H, Freer G et al (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339\u2013342","journal-title":"Nature"},{"key":"9551_CR86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(95)01501-9","volume":"713","author":"T Kossmann","year":"1996","unstructured":"Kossmann T, Hans V, Imhof HG et al (1996) Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 713:143\u2013152","journal-title":"Brain Res"},{"key":"9551_CR87","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.20692","volume":"51","author":"E Kozora","year":"2004","unstructured":"Kozora E, Ellison MC, West S (2004) Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum 51:810\u2013818","journal-title":"Arthritis Rheum"},{"key":"9551_CR88","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0961203311429116","volume":"21","author":"E Kozora","year":"2012","unstructured":"Kozora E, Filley CM, Zhang L et al (2012) Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations. Lupus 21:402\u2013411","journal-title":"Lupus"},{"key":"9551_CR89","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.exger.2004.01.009","volume":"39","author":"KS Krabbe","year":"2004","unstructured":"Krabbe KS, Pedersen M, Bruunsgaard H (2004) Inflammatory mediators in the elderly. Experimental Gerontology 39:687\u2013699","journal-title":"Experimental Gerontology"},{"key":"9551_CR90","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bbi.2005.04.010","volume":"19","author":"KS Krabbe","year":"2005","unstructured":"Krabbe KS, Reichenberg A, Yirmiya R et al (2005) Low-dose endotoxemia and human neuropsychological functions. BRAIN, BEHAVIOUR, AND IMMUNITY 19:453\u2013460","journal-title":"BRAIN, BEHAVIOUR, AND IMMUNITY"},{"key":"9551_CR91","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0168-0102(92)90039-F","volume":"13","author":"Y Kushima","year":"1992","unstructured":"Kushima Y, Hama T, Hatanaka H (1992) Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci Res 13:267\u2013280","journal-title":"Neurosci Res"},{"key":"9551_CR92","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0304-3940(92)90244-2","volume":"143","author":"Y Kushima","year":"1992","unstructured":"Kushima Y, Hatanaka H (1992) Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci Lett 143:110\u2013114","journal-title":"Neurosci Lett"},{"key":"9551_CR93","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002093-199809000-00016","volume":"12","author":"AS Lanzrein","year":"1998","unstructured":"Lanzrein AS, Johnston CM, Perry VH et al (1998) Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord 12:215\u2013227","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"9551_CR94","first-page":"921","volume":"24","author":"F Licastro","year":"2003","unstructured":"Licastro F, Grimaldi LME, Bonaf\u00e8 M et al (2003) Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. NBA 24:921\u2013926","journal-title":"NBA"},{"key":"9551_CR95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-5728(99)00226-X","volume":"103","author":"F Licastro","year":"2000","unstructured":"Licastro F, Pedrini S, Caputo L et al (2000) Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? Journal of Neuroimmunology 103:97\u2013102","journal-title":"Journal of Neuroimmunology"},{"key":"9551_CR96","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/B978-0-444-52910-7.00050-7","volume":"112","author":"L Lim","year":"2013","unstructured":"Lim L, Lippe S, Silverman E (2013) Effect of autoimmune diseases on cognitive function. Handb Clin Neurol 112:1275\u20131283","journal-title":"Handb Clin Neurol"},{"key":"9551_CR97","first-page":"117","volume":"147","author":"M Linker-Israeli","year":"1991","unstructured":"Linker-Israeli M, Deans RJ, Wallace DJ et al (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis J Immunol 147:117\u2013123","journal-title":"A putative role in pathogenesis. J Immunol"},{"key":"9551_CR98","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1872-034X.2012.01047.x","volume":"42","author":"M Luo","year":"2012","unstructured":"Luo M, Li L, Yang E-N, Cao W-K (2012) Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis. Hepatol Res 42:1202\u20131210","journal-title":"Hepatol Res"},{"key":"9551_CR99","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.biopsych.2008.04.016","volume":"64","author":"AL Marsland","year":"2008","unstructured":"Marsland AL, Gianaros PJ, Abramowitch SM et al (2008) Interleukin-6 Covaries Inversely with Hippocampal Grey Matter Volume in Middle-Aged Adults. Biological Psychiatry 64:484\u2013490","journal-title":"Biological Psychiatry"},{"key":"9551_CR100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0006-8993(00)02363-5","volume":"869","author":"M Mart\u00ednez","year":"2000","unstructured":"Mart\u00ednez M, Fern\u00e1ndez-Vivancos E, Frank A et al (2000) Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations. Brain Res 869:216\u2013219","journal-title":"Brain Res"},{"key":"9551_CR101","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1196\/annals.1366.021","volume":"1088","author":"G Mastorakos","year":"2006","unstructured":"Mastorakos G, Ilias I (2006) Interleukin-6: a cytokine and\/or a major modulator of the response to somatic stress. Ann N Y Acad Sci 1088:373\u2013381","journal-title":"Ann N Y Acad Sci"},{"key":"9551_CR102","doi-asserted-by":"crossref","first-page":"9950","DOI":"10.1016\/S0021-9258(18)92911-X","volume":"266","author":"LT May","year":"1991","unstructured":"May LT, Santhanam U, Sehgal PB (1991) On the multimeric nature of natural human interleukin-6. J Biol Chem 266:9950\u20139955","journal-title":"J Biol Chem"},{"key":"9551_CR103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(97)00886-0","volume":"239","author":"P M\u00e4rz","year":"1997","unstructured":"M\u00e4rz P, Heese K, Hock C et al (1997) Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 239:29\u201332","journal-title":"Neurosci Lett"},{"key":"9551_CR104","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113\u20131124","journal-title":"Neurology"},{"key":"9551_CR105","first-page":"1544","volume":"20","author":"JL Mege","year":"1993","unstructured":"Mege JL, Dilsen N, Sanguedolce V et al (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et's disease. A comparative study with familial Mediterranean fever and healthy subjects J Rheumatol 20:1544\u20131549","journal-title":"A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol"},{"key":"9551_CR106","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2004.02.021","volume":"220","author":"R Monastero","year":"2004","unstructured":"Monastero R, Camarda C, Pipia C et al (2004) Cognitive impairment in Beh\u00e7et's disease patients without overt neurological involvement. Journal of the Neurological Sciences 220:99\u2013104","journal-title":"Journal of the Neurological Sciences"},{"key":"9551_CR107","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.24043","volume":"53","author":"S Montagnese","year":"2011","unstructured":"Montagnese S, Biancardi A, Schiff S et al (2011) Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology 53:558\u2013566","journal-title":"Hepatology"},{"key":"9551_CR108","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.1088417","volume":"302","author":"ML Monje","year":"2003","unstructured":"Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760\u20131765","journal-title":"Science"},{"key":"9551_CR109","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/ajg.2011.123","volume":"106","author":"C Montoliu","year":"2011","unstructured":"Montoliu C, Cauli O, Urios A et al (2011) 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol 106:1629\u20131637","journal-title":"Am J Gastroenterol"},{"key":"9551_CR110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31815e7f58","volume":"43","author":"C Montoliu","year":"2009","unstructured":"Montoliu C, Piedrafita B, Serra MA et al (2009) IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 43:272\u2013279","journal-title":"J Clin Gastroenterol"},{"key":"9551_CR111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/joim.12052","volume":"274","author":"SP Mooijaart","year":"2013","unstructured":"Mooijaart SP, Sattar N, Trompet S et al (2013) Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. J Intern Med 274:77\u201385","journal-title":"J Intern Med"},{"key":"9551_CR112","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1523\/JNEUROSCI.15-07-05130.1995","volume":"15","author":"PG Murphy","year":"1995","unstructured":"Murphy PG, Grondin J, Altares M, Richardson PM (1995) Induction of interleukin-6 in axotomized sensory neurons. J Neurosci 15:5130\u20135138","journal-title":"J Neurosci"},{"key":"9551_CR113","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0006-291X(88)81305-6","volume":"155","author":"Y Naitoh","year":"1988","unstructured":"Naitoh Y, Fukata J, Tominaga T et al (1988) Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 155:1459\u20131463","journal-title":"Biochem Biophys Res Commun"},{"key":"9551_CR114","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1111\/j.1460-9568.2004.03706.x","volume":"20","author":"TE Nelson","year":"2004","unstructured":"Nelson TE, Netzeband JG, Gruol DL (2004) Chronic interleukin-6 exposure alters metabotropic glutamate receptor-activated calcium signalling in cerebellar Purkinje neurons. Eur J Neurosci 20:2387\u20132400","journal-title":"Eur J Neurosci"},{"key":"9551_CR115","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1113\/jphysiol.2002.022285","volume":"542","author":"L Nybo","year":"2002","unstructured":"Nybo L, Nielsen B, Pedersen BK et al (2002) Interleukin-6 release from the human brain during prolonged exercise. J Physiol (Lond) 542:991\u2013995","journal-title":"J Physiol (Lond)"},{"key":"9551_CR116","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004150050317","volume":"246","author":"O Oktem-Tan\u00f6r","year":"1999","unstructured":"Oktem-Tan\u00f6r O, Baykan-Kurt B, G\u00fcrvit IH et al (1999) Neuropsychological follow-up of 12 patients with neuro-Beh\u00e7et disease. J Neurol 246:113\u2013119","journal-title":"J Neurol"},{"key":"9551_CR117","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood.V92.10.3495","volume":"92","author":"M Peters","year":"1998","unstructured":"Peters M, M\u00fcller AM, Rose-John S (1998) Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 92:3495\u20133504","journal-title":"Blood"},{"key":"9551_CR118","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.jhh.1001462","volume":"16","author":"R Pola","year":"2002","unstructured":"Pola R, Flex A, Gaetani E et al (2002) The \u2212174 G\/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population. J Hum Hypertens 16:637\u2013640","journal-title":"J Hum Hypertens"},{"key":"9551_CR119","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/01.STR.25.7.1393","volume":"25","author":"W Pugsley","year":"1994","unstructured":"Pugsley W, Klinger L, Paschalis C et al (1994) The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 25:1393\u20131399","journal-title":"Stroke"},{"key":"9551_CR120","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1523\/JNEUROSCI.18-24-10445.1998","volume":"18","author":"Z Qiu","year":"1998","unstructured":"Qiu Z, Sweeney DD, Netzeband JG, Gruol DL (1998) Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci 18:10445\u201310456","journal-title":"J Neurosci"},{"key":"9551_CR121","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/psy.0b013e318068fce4","volume":"69","author":"SB Rafnsson","year":"2007","unstructured":"Rafnsson SB, Deary IJ, Smith FB et al (2007) Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study. Psychosom Med 69:425\u2013434","journal-title":"Psychosom Med"},{"key":"9551_CR122","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","volume":"8","author":"S Rose-John","year":"2012","unstructured":"Rose-John S (2012) IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci 8:1237\u20131247","journal-title":"Int J Biol Sci"},{"key":"9551_CR123","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","volume":"53C","author":"JD Rosenblat","year":"2014","unstructured":"Rosenblat JD, Cha DS, Mansur RB, McIntyre RS (2014) Inflamed moods: A review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 53C:23\u201334","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9551_CR124","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0891988710373598","volume":"23","author":"LS Rothenburg","year":"2010","unstructured":"Rothenburg LS, Herrmann N, Swardfager W et al (2010) The relationship between inflammatory markers and post stroke cognitive impairment. J Geriatr Psychiatry Neurol 23:199\u2013205","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"9551_CR125","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G (1999) Beh\u00e7et's disease. N Engl J Med 341:1284\u20131291","journal-title":"N Engl J Med"},{"key":"9551_CR126","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0197-4580(03)00010-1","volume":"24","author":"G Sala","year":"2003","unstructured":"Sala G, Galimberti G, Canevari C et al (2003) Peripheral cytokine release in Alzheimer patients: correlation with disease severity. Neurobiology of Aging 24:909\u2013914","journal-title":"Neurobiology of Aging"},{"key":"9551_CR127","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5223(19)38989-5","volume":"84","author":"JA Savageau","year":"1982","unstructured":"Savageau JA, Stanton BA, Jenkins CD, Frater RW (1982) Neuropsychological dysfunction following elective cardiac operation. II A six-month reassessment J Thorac Cardiovasc Surg 84:595\u2013600","journal-title":"II. A six-month reassessment. J Thorac Cardiovasc Surg"},{"key":"9551_CR128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-3-211-45295-0_57","volume":"70","author":"M Sawada","year":"2006","unstructured":"Sawada M, Imamura K, Nagatsu T (2006) Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm Suppl 70:373\u2013381","journal-title":"J Neural Transm Suppl"},{"key":"9551_CR129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0736-5748(94)00076-F","volume":"13","author":"M Sawada","year":"1995","unstructured":"Sawada M, Suzumura A, Marunouchi T (1995) Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci 13:253\u2013264","journal-title":"Int J Dev Neurosci"},{"key":"9551_CR130","first-page":"321","volume":"23","author":"N Sayinalp","year":"1996","unstructured":"Sayinalp N, Ozcebe OI, Ozdemir O et al (1996) Cytokines in Beh\u00e7et's disease. J Rheumatol 23:321\u2013322","journal-title":"J Rheumatol"},{"key":"9551_CR131","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1179\/1743132812Y.0000000073","volume":"34","author":"F S\u00e1nchez-L\u00f3pez","year":"2012","unstructured":"S\u00e1nchez-L\u00f3pez F, Tasset I, Ag\u00fcera E et al (2012) Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease. Neurol Res 34:721\u2013724","journal-title":"Neurol Res"},{"key":"9551_CR132","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0301-0082(94)90034-5","volume":"44","author":"B Sch\u00f6bitz","year":"1994","unstructured":"Sch\u00f6bitz B, de Kloet ER, Holsboer F (1994) Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 44:397\u2013432","journal-title":"Prog Neurobiol"},{"key":"9551_CR133","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1460-9568.1993.tb00210.x","volume":"5","author":"B Sch\u00f6bitz","year":"1993","unstructured":"Sch\u00f6bitz B, de Kloet ER, Sutanto W, Holsboer F (1993) Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci 5:1426\u20131435","journal-title":"Eur J Neurosci"},{"key":"9551_CR134","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0304-3940(94)90003-5","volume":"174","author":"F Shalit","year":"1994","unstructured":"Shalit F, Sredni B, Stern L et al (1994) Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients. Neurosci Lett 174:130\u2013132","journal-title":"Neurosci Lett"},{"key":"9551_CR135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","volume":"114","author":"LS Shapiro","year":"2012","unstructured":"Shapiro LS, Farrell J, Haghighi AB (2012) Tocilizumab treatment for neuro-Behcet's disease, the first report. Clin Neurol Neurosurg 114:297\u2013298","journal-title":"Clin Neurol Neurosurg"},{"key":"9551_CR136","first-page":"259","volume":"62","author":"PJ Shaw","year":"1987","unstructured":"Shaw PJ, Bates D, Cartlidge NE et al (1987) Long-term intellectual dysfunction following coronary artery bypass graft surgery: a six month follow-up study. Q J Med 62:259\u2013268","journal-title":"Q J Med"},{"key":"9551_CR137","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ajmg.10417","volume":"114","author":"N Shibata","year":"2002","unstructured":"Shibata N, Ohnuma T, Takahashi T et al (2002) Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 114:436\u2013439","journal-title":"Am J Med Genet"},{"key":"9551_CR138","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4049\/jimmunol.155.3.1489","volume":"155","author":"P Shrikant","year":"1995","unstructured":"Shrikant P, Weber E, Jilling T, Benveniste EN (1995) Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6. J Immunol 155:1489\u20131501","journal-title":"J Immunol"},{"key":"9551_CR139","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","volume":"20","author":"A Silvestroni","year":"2009","unstructured":"Silvestroni A, Faull RLM, Strand AD, M\u00f6ller T (2009) Distinct neuroinflammatory profile in post-mortem human Huntington's disease. Neuroreport 20:1098\u20131103","journal-title":"Neuroreport"},{"key":"9551_CR140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3956(97)00023-X","volume":"31","author":"VK Singh","year":"1997","unstructured":"Singh VK, Guthikonda P (1997) Circulating cytokines in Alzheimer's disease. J Psychiatr Res 31:657\u2013660","journal-title":"J Psychiatr Res"},{"key":"9551_CR141","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2249.1992.tb05840.x","volume":"90","author":"PE Spronk","year":"1992","unstructured":"Spronk PE, ter Borg EJ, Limburg PC, Kallenberg CG (1992) Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity? Clin Exp Immunol 90:106\u2013110","journal-title":"Clin Exp Immunol"},{"key":"9551_CR142","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-8993(94)90329-8","volume":"652","author":"SC Steffensen","year":"1994","unstructured":"Steffensen SC, Campbell IL, Henriksen SJ (1994) Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res 652:149\u2013153","journal-title":"Brain Res"},{"key":"9551_CR143","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","volume":"41","author":"A Stojanovic","year":"2014","unstructured":"Stojanovic A, Martorell L, Montalvo I et al (2014) Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms. Psychoneuroendocrinology 41:23\u201332","journal-title":"Psychoneuroendocrinology"},{"key":"9551_CR144","first-page":"223","volume":"66","author":"S Strauss","year":"1992","unstructured":"Strauss S, Bauer J, Ganter U et al (1992) Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66:223\u2013230","journal-title":"Lab Invest"},{"key":"9551_CR145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0304-3940(02)00469-X","volume":"328","author":"PK Stys","year":"2002","unstructured":"Stys PK, Jiang Q (2002) Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons. Neurosci Lett 328:150\u2013154","journal-title":"Neurosci Lett"},{"key":"9551_CR146","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(99)00051-8","volume":"262","author":"S Suzuki","year":"1999","unstructured":"Suzuki S, Tanaka K, Nagata E et al (1999) Cerebral neurons express interleukin-6 after transient forebrain ischemia in gerbils. Neurosci Lett 262:117\u2013120","journal-title":"Neurosci Lett"},{"key":"9551_CR147","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1471-4159.2000.0750634.x","volume":"75","author":"V Tancredi","year":"2000","unstructured":"Tancredi V, D'Antuono M, Caf\u00e8 C et al (2000) The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J Neurochem 75:634\u2013643","journal-title":"J Neurochem"},{"key":"9551_CR148","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1020568013953","volume":"19","author":"E Tarkowski","year":"1999","unstructured":"Tarkowski E, Blennow K, Wallin A, Tarkowski A (1999) Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 19:223\u2013230","journal-title":"J Clin Immunol"},{"key":"9551_CR149","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0361-9230(03)00088-1","volume":"61","author":"E Tarkowski","year":"2003","unstructured":"Tarkowski E, Liljeroth AM, Minthon L et al (2003) Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull 61:255\u2013260","journal-title":"Brain Res Bull"},{"key":"9551_CR150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/jnnp.57.2.202","volume":"57","author":"TK Tatemichi","year":"1994","unstructured":"Tatemichi TK, Desmond DW, Stern Y et al (1994) Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatr 57:202\u2013207","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"9551_CR151","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-3940(92)90713-H","volume":"144","author":"S Toulmond","year":"1992","unstructured":"Toulmond S, Vige X, Fage D, Benavides J (1992) Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett 144:49\u201352","journal-title":"Neurosci Lett"},{"key":"9551_CR152","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/096120330000900704","volume":"9","author":"E Trysberg","year":"2000","unstructured":"Trysberg E, Carlsten H, Tarkowski A (2000) Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 9:498\u2013503","journal-title":"Lupus"},{"key":"9551_CR153","first-page":"S73","volume":"30","author":"P Urbaniak","year":"2012","unstructured":"Urbaniak P, Hasler P, Kretzschmar S (2012) Refractory neuro-Beh\u00e7et treated by tocilizumab: a case report. Clin Exp Rheumatol 30:S73\u20135","journal-title":"Clin Exp Rheumatol"},{"key":"9551_CR154","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1523\/JNEUROSCI.22-02-00486.2002","volume":"22","author":"L Valli\u00e8res","year":"2002","unstructured":"Valli\u00e8res L, Campbell IL, Gage FH, Sawchenko PE (2002) Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci 22:486\u2013492","journal-title":"J Neurosci"},{"key":"9551_CR155","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1046\/j.1471-4159.1997.69041668.x","volume":"69","author":"L Valli\u00e8res","year":"1997","unstructured":"Valli\u00e8res L, Rivest S (1997) Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta. J Neurochem 69:1668\u20131683","journal-title":"J Neurochem"},{"key":"9551_CR156","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0304-3940(90)90666-W","volume":"108","author":"CM Duijn van","year":"1990","unstructured":"van Duijn CM, Hofman A, Nagelkerken L (1990) Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease. Neurosci Lett 108:350\u2013354","journal-title":"Neurosci Lett"},{"key":"9551_CR157","doi-asserted-by":"crossref","first-page":"15959","DOI":"10.1073\/pnas.232432399","volume":"99","author":"JN Varghese","year":"2002","unstructured":"Varghese JN, Moritz RL, Lou M-Z et al (2002) Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain. Proc Natl Acad Sci USA 99:15959\u201315964","journal-title":"Proc Natl Acad Sci USA"},{"key":"9551_CR158","doi-asserted-by":"crossref","first-page":"M326","DOI":"10.1093\/gerona\/57.5.M326","volume":"57","author":"M Visser","year":"2002","unstructured":"Visser M, Pahor M, Taaffe DR et al (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57:M326\u201332","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"9551_CR159","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0404.2004.00286.x","volume":"110","author":"K Wada-Isoe","year":"2004","unstructured":"Wada-Isoe K, Wakutani Y, Urakami K, Nakashima K (2004) Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol Scand 110:124\u2013127","journal-title":"Acta Neurol Scand"},{"key":"9551_CR160","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0006-291X(02)00230-9","volume":"293","author":"K Wallenius","year":"2002","unstructured":"Wallenius K, Wallenius V, Sunter D et al (2002) Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 293:560\u2013565","journal-title":"Biochem Biophys Res Commun"},{"key":"9551_CR161","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0197-0186(98)00016-3","volume":"33","author":"J Wang","year":"1998","unstructured":"Wang J, Dunn AJ (1998) Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochemistry International 33:143\u2013154","journal-title":"Neurochemistry International"},{"key":"9551_CR162","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/rheumatology\/41.4.411","volume":"41","author":"K Waterloo","year":"2002","unstructured":"Waterloo K, Omdal R, Husby G, Mellgren SI (2002) Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology (Oxford) 41:411\u2013415","journal-title":"Rheumatology (Oxford)"},{"key":"9551_CR163","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.59.3.371","volume":"59","author":"JD Weaver","year":"2002","unstructured":"Weaver JD, Huang M-H, Albert M et al (2002) Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59:371\u2013378","journal-title":"Neurology"},{"key":"9551_CR164","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuroscience.2013.08.025","volume":"252","author":"H Wei","year":"2013","unstructured":"Wei H, Alberts I, Li X (2013) Brain IL-6 and autism. Neuroscience 252:320\u2013325","journal-title":"Neuroscience"},{"key":"9551_CR165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-8993(93)91327-O","volume":"629","author":"JA Wood","year":"1993","unstructured":"Wood JA, Wood PL, Ryan R et al (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res 629:245\u2013252","journal-title":"Brain Res"},{"key":"9551_CR166","first-page":"57","volume":"10","author":"Y Wu","year":"1999","unstructured":"Wu Y, Shaghaghi EK, Jacquot C et al (1999) Synergism between interleukin-6 and interleukin-1beta in hypothalamic serotonin release: a reverse in vivo microdialysis study in F344 rats. Eur Cytokine Netw 10:57\u201364","journal-title":"Eur Cytokine Netw"},{"key":"9551_CR167","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-5728(99)00050-8","volume":"97","author":"E Xiao","year":"1999","unstructured":"Xiao E, Xia L, Ferin M, Wardlaw SL (1999) Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin-1 receptor antagonist into peripheral blood in the primate. Journal of Neuroimmunology 97:70\u201376","journal-title":"Journal of Neuroimmunology"},{"key":"9551_CR168","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","volume":"292","author":"K Yaffe","year":"2004","unstructured":"Yaffe K, Kanaya A, Lindquist K et al (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292:2237\u20132242","journal-title":"JAMA"},{"key":"9551_CR169","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-8993(94)90023-X","volume":"643","author":"M Yamada","year":"1994","unstructured":"Yamada M, Hatanaka H (1994) Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res 643:173\u2013180","journal-title":"Brain Res"},{"key":"9551_CR170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0923-1811(95)00439-4","volume":"11","author":"Y Yamakawa","year":"1996","unstructured":"Yamakawa Y, Sugita Y, Nagatani T et al (1996) Interleukin-6 (IL-6) in patients with Beh\u00e7et's disease. J Dermatol Sci 11:189\u2013195","journal-title":"J Dermatol Sci"},{"key":"9551_CR171","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(94)90006-X","volume":"643","author":"S Zalcman","year":"1994","unstructured":"Zalcman S, Green-Johnson JM, Murray L et al (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, \u22122 and \u22126. Brain Res 643:40\u201349","journal-title":"Brain Res"},{"key":"9551_CR172","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0197-0186(00)00099-1","volume":"38","author":"J Zhang","year":"2001","unstructured":"Zhang J, Terreni L, De Simoni MG, Dunn AJ (2001) Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum. Neurochemistry International 38:303\u2013308","journal-title":"Neurochemistry International"},{"key":"9551_CR173","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cyto.2011.11.006","volume":"57","author":"S-J Zhao","year":"2012","unstructured":"Zhao S-J, Guo C-N, Wang M-Q et al (2012) Serum levels of inflammation factors and cognitive performance in amnestic mild cognitive impairment: a Chinese clinical study. Cytokine 57:221\u2013225","journal-title":"Cytokine"},{"key":"9551_CR174","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1523\/JNEUROSCI.19-11-04305.1999","volume":"19","author":"J Zhong","year":"1999","unstructured":"Zhong J, Dietzel ID, Wahle P et al (1999) Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice. J Neurosci 19:4305\u20134313","journal-title":"J Neurosci"},{"key":"9551_CR175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/gps.1674","volume":"22","author":"G Zuliani","year":"2007","unstructured":"Zuliani G, Guerra G, Ranzini M et al (2007a) High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia. Int J Geriatr Psychiatry 22:305\u2013311","journal-title":"Int J Geriatr Psychiatry"},{"key":"9551_CR176","doi-asserted-by":"crossref","unstructured":"Zuliani G, Ranzini M, Guerra G, et al. (2007b) Plasma cytokines profile in older subjects with late onset Alzheimer\u2019s disease or vascular dementia. J Psychiatr Res 41:686\u2013693","DOI":"10.1016\/j.jpsychires.2006.02.008"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-014-9551-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-014-9551-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-014-9551-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T13:13:27Z","timestamp":1689167607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-014-9551-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":176,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["9551"],"URL":"https:\/\/doi.org\/10.1007\/s11011-014-9551-2","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]}}}